Infraredx, Inc.

34 Third Ave.
Burlington,  MA  01803

United States
  • Booth: 758


Infraredx, Inc., a Nipro company, is advancing the diagnosis and management of coronary artery disease by providing cardiologists with the most precise imaging tools required to predict and ultimately prevent heart attacks. Its Makoto™ Intravascular Imaging System, with accompanying Dualpro™ IVUS+NIRS catheter, is the only technology on the market that is FDA-cleared for the detection of lipid core plaque (LCP). LCP, suspected to be vulnerable plaque, is well-documented in studies as the cause of most serious heart attacks. Infraredx is dedicated to advancing this important field of research and conducting landmark clinical trials to transform how we view and treat heart disease. Come by booth #758 for a demo of the Makoto Imaging System.

 Additional Info

ACC.19 Learning Pathways? (select one)
Interventional Cardiology